Jpmorgan Chase & CO Neogenomics Inc Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Neogenomics Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 607,332 shares of NEO stock, worth $5.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
607,332
Previous 439,347 38.24%
Holding current value
$5.78 Million
Previous $6.48 Million 54.44%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$13.0 - $18.43 $2.18 Million - $3.1 Million
167,985 Added 38.24%
607,332 $10 Million
Q3 2024

Dec 26, 2024
SELL
$13.4 - $17.73 $10.4 Million - $13.8 Million
-779,672 Reduced 63.96%
439,347 $6.48 Million
Q3 2024

Nov 08, 2024
SELL
$13.4 - $17.73 $10.4 Million - $13.8 Million
-779,672 Reduced 63.96%
439,347 $6.48 Million
Q2 2024

Dec 26, 2024
BUY
$13.01 - $15.77 $10.1 Million - $12.3 Million
779,672 Added 177.46%
1,219,019 $16.9 Million
Q2 2024

Aug 12, 2024
BUY
$13.01 - $15.77 $3.12 Million - $3.78 Million
239,648 Added 24.47%
1,219,019 $16.9 Million
Q1 2024

Dec 26, 2024
BUY
$14.06 - $16.79 $7.59 Million - $9.07 Million
540,024 Added 122.92%
979,371 $15.4 Million
Q1 2024

May 10, 2024
BUY
$14.06 - $16.79 $2.58 Million - $3.08 Million
183,634 Added 23.08%
979,371 $15.4 Million
Q4 2023

Dec 26, 2024
BUY
$11.67 - $20.73 $4.16 Million - $7.39 Million
356,390 Added 81.12%
795,737 $12.9 Million
Q4 2023

Feb 12, 2024
SELL
$11.67 - $20.73 $3.67 Million - $6.53 Million
-314,846 Reduced 28.35%
795,737 $12.9 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $233,134 - $342,505
-19,188 Reduced 1.7%
1,110,583 $13.7 Million
Q2 2023

Aug 11, 2023
SELL
$14.1 - $19.83 $967,316 - $1.36 Million
-68,604 Reduced 5.72%
1,129,771 $18.2 Million
Q1 2023

May 18, 2023
BUY
$9.09 - $19.45 $1.44 Million - $3.08 Million
158,281 Added 15.22%
1,198,375 $20.9 Million
Q1 2023

May 11, 2023
SELL
$9.09 - $19.45 $4.23 Million - $9.04 Million
-465,023 Reduced 30.9%
1,040,094 $18.1 Million
Q4 2022

Feb 13, 2023
BUY
$6.45 - $12.07 $2.82 Million - $5.29 Million
437,910 Added 41.03%
1,505,117 $13.9 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $6.41 Million - $10.5 Million
815,539 Added 324.05%
1,067,207 $9.19 Million
Q2 2022

Aug 11, 2022
BUY
$7.06 - $13.97 $851,548 - $1.69 Million
120,616 Added 92.04%
251,668 $2.05 Million
Q1 2022

May 11, 2022
BUY
$12.15 - $35.28 $211,543 - $614,260
17,411 Added 15.32%
131,052 $1.59 Million
Q4 2021

Feb 10, 2022
BUY
$30.49 - $48.49 $961,989 - $1.53 Million
31,551 Added 38.43%
113,641 $3.88 Million
Q3 2021

Nov 12, 2021
BUY
$41.66 - $52.52 $3.42 Million - $4.31 Million
82,090 New
82,090 $3.96 Million

Others Institutions Holding NEO

# of Institutions
282
Shares Held
124M
Call Options Held
751K
Put Options Held
107K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.2B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email